Your browser doesn't support javascript.
loading
Efficacy and safety of zibotentan and dapagliflozin in patients with chronic kidney disease: study design and baseline characteristics of the ZENITH-CKD trial.
Heerspink, Hiddo J L; Greasley, Peter J; Ahlström, Christine; Althage, Magnus; Dwyer, Jamie P; Law, Gordon; Wijkmark, Emma; Lin, Min; Mercier, Anne-Kristina; Sunnåker, Mikael; Turton, Michelle; Wheeler, David C; Ambery, Philip.
Afiliación
  • Heerspink HJL; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Greasley PJ; The George Institute for Global Health, Sydney, New South Wales, Australia.
  • Ahlström C; Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Althage M; DMPK, Research and Early Development Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Dwyer JP; Translational Science & Experimental Medicine, Research and Early Development Cardiovascular, Renal, and Metabolism, Biopharmaceutical R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Law G; Division of Nephrology/Hypertension, University of Utah Health, Salt Lake City, UT, USA.
  • Wijkmark E; Early Biometrics & Statistical Innovation, Data Science and Artificial Intelligence, R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Lin M; Biometrics Late Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Mercier AK; Biometrics Late Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Sunnåker M; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden.
  • Turton M; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden.
  • Wheeler DC; Biopharma Clinical Operations, Early CVRM, AstraZeneca, Cambridge, UK.
  • Ambery P; Department of Renal Medicine, University College London, London, UK.
Nephrol Dial Transplant ; 39(3): 414-425, 2024 Feb 28.
Article en En | MEDLINE | ID: mdl-37632201
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pirrolidinas / Compuestos de Bencidrilo / Diabetes Mellitus Tipo 2 / Insuficiencia Renal Crónica / Inhibidores del Cotransportador de Sodio-Glucosa 2 / Glucósidos Tipo de estudio: Clinical_trials / Guideline Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Nephrol Dial Transplant Asunto de la revista: NEFROLOGIA / TRANSPLANTE Año: 2024 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pirrolidinas / Compuestos de Bencidrilo / Diabetes Mellitus Tipo 2 / Insuficiencia Renal Crónica / Inhibidores del Cotransportador de Sodio-Glucosa 2 / Glucósidos Tipo de estudio: Clinical_trials / Guideline Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Nephrol Dial Transplant Asunto de la revista: NEFROLOGIA / TRANSPLANTE Año: 2024 Tipo del documento: Article País de afiliación: Países Bajos